Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 12
24
Diseases
124
Unique genes
0.229
Avg. similarity score
Glucose-6-phosphate dehydrogenase deficiency
Most-connected disease (11 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Glucose-6-phosphate dehydrogenase deficiency
Anhidrotic ectodermal dysplasia with immunodeficiency, osteopetrosis, and lymphedema
Autoinflammatory disease, systemic, x-linked
Bloch sulzberger syndrome
Congenital nonspherocytic hemolytic anemia
G6PD deficiency
Granulomatous disease
anemia, nonspherocytic hemolytic, due to G6PD deficiency
Hyper-igm immunodeficiency syndrome
IKBKG-related immunodeficiency with or without ectodermal dysplasia
incontinentia pigmenti
Hemolytic anemia
Hereditary hemolytic anemia
Pleural diseases
Coronary vessel anomalies
Uridine monophosphate hydrolase deficiency
Williams syndrome
inherited glutathione synthetase deficiency
Charcot-Marie-Tooth disease type 4B2
Endometrioid carcinoma
Occupational disease
Peritonitis
immunodeficiency, common variable, 2
leber-like hereditary optic neuropathy, autosomal recessive 1
Member diseases (most connected first ‐ the cluster's core)
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| G6PD | 10 / 24 | anemia, nonspherocytic hemolytic, due to G6PD deficiency, Anhidrotic ectodermal dysplasia with immunodeficiency, osteopetrosis, and lymphedema, Autoinflammatory disease, systemic, x-linked, Bloch sulzberger syndrome and 6 more |
| IKBKG | 8 / 24 | Anhidrotic ectodermal dysplasia with immunodeficiency, osteopetrosis, and lymphedema, Autoinflammatory disease, systemic, x-linked, Bloch sulzberger syndrome, Congenital nonspherocytic hemolytic anemia and 4 more |
| GCLC | 4 / 24 | Congenital nonspherocytic hemolytic anemia, Coronary vessel anomalies, Hemolytic anemia, Hereditary hemolytic anemia |
| IFNG | 4 / 24 | Glucose-6-phosphate dehydrogenase deficiency, Granulomatous disease, Peritonitis, Pleural diseases |
| GPI | 3 / 24 | Congenital nonspherocytic hemolytic anemia, Hemolytic anemia, Hereditary hemolytic anemia |
| GSS | 3 / 24 | Congenital nonspherocytic hemolytic anemia, Hereditary hemolytic anemia, inherited glutathione synthetase deficiency |
| HK1 | 3 / 24 | Congenital nonspherocytic hemolytic anemia, Hemolytic anemia, Hereditary hemolytic anemia |
| NT5C3A | 3 / 24 | Congenital nonspherocytic hemolytic anemia, Hemolytic anemia, Uridine monophosphate hydrolase deficiency |
| AK1 | 2 / 24 | Congenital nonspherocytic hemolytic anemia, Hemolytic anemia |
| BPGM | 2 / 24 | Hemolytic anemia, Hereditary hemolytic anemia |
| CARD8 | 2 / 24 | Occupational disease, Pleural diseases |
| DNAJC30 | 2 / 24 | leber-like hereditary optic neuropathy, autosomal recessive 1, Williams syndrome |
| GATA1 | 2 / 24 | Congenital nonspherocytic hemolytic anemia, Hemolytic anemia |
| GSR | 2 / 24 | Congenital nonspherocytic hemolytic anemia, Hemolytic anemia |
| HBB | 2 / 24 | Hemolytic anemia, Hereditary hemolytic anemia |
| IL6 | 2 / 24 | Glucose-6-phosphate dehydrogenase deficiency, Pleural diseases |
| MSLN | 2 / 24 | Endometrioid carcinoma, Pleural diseases |
| NCF1 | 2 / 24 | Granulomatous disease, Williams syndrome |
| PKLR | 2 / 24 | Congenital nonspherocytic hemolytic anemia, Hemolytic anemia |
| RNF157 | 2 / 24 | Granulomatous disease, Williams syndrome |
| SBF2 | 2 / 24 | Charcot-Marie-Tooth disease type 4B2, Hemolytic anemia |
| TGFB1 | 2 / 24 | Occupational disease, Pleural diseases |
| TIMP2 | 2 / 24 | Occupational disease, Pleural diseases |
| TNFRSF13B | 2 / 24 | Hyper-igm immunodeficiency syndrome, immunodeficiency, common variable, 2 |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Cross-presentation of particulate exogenous antigens (phagosomes) | Reactome | 5 / 8 | 60.5× | 5.91e-9 | 5.54e-7 ✓ sig. |
| Leishmaniasis | KEGG | 10 / 78 | 12.4× | 6.64e-9 | 6.12e-7 ✓ sig. |
| Intestinal immune network for IgA production | KEGG | 8 / 50 | 15.5× | 3.84e-8 | 2.82e-6 ✓ sig. |
| Malaria | KEGG | 8 / 50 | 15.5× | 3.84e-8 | 2.82e-6 ✓ sig. |
| Detoxification of Reactive Oxygen Species | Reactome | 7 / 34 | 19.9× | 4.50e-8 | 3.25e-6 ✓ sig. |
| Lipid and atherosclerosis | KEGG | 14 / 216 | 6.3× | 4.62e-8 | 3.33e-6 ✓ sig. |
| RHO GTPases Activate NADPH Oxidases | Reactome | 6 / 24 | 24.2× | 1.24e-7 | 7.89e-6 ✓ sig. |
| Glycolysis | Reactome | 6 / 28 | 20.8× | 3.36e-7 | 1.89e-5 ✓ sig. |
| Primary immunodeficiency | KEGG | 6 / 38 | 15.3× | 2.26e-6 | 9.78e-5 ✓ sig. |
| Fluid shear stress and atherosclerosis | KEGG | 9 / 141 | 6.2× | 1.48e-5 | 4.66e-4 ✓ sig. |
| ROS and RNS production in phagocytes | Reactome | 5 / 34 | 14.2× | 2.37e-5 | 6.85e-4 ✓ sig. |
| Allograft rejection | KEGG | 5 / 39 | 12.4× | 4.70e-5 | 1.21e-3 ✓ sig. |
| Diabetic cardiomyopathy | KEGG | 10 / 205 | 4.7× | 5.07e-5 | 1.29e-3 ✓ sig. |
| Cytokine-cytokine receptor interaction | KEGG | 12 / 298 | 3.9× | 5.83e-5 | 1.45e-3 ✓ sig. |
| Glycolysis / Gluconeogenesis | KEGG | 6 / 67 | 8.7× | 6.40e-5 | 1.56e-3 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| inflammatory response | GO:0006954 | 17 / 467 | 5.5× | 1.28e-8 | 2.12e-6 ✓ sig. |
| respiratory burst | GO:0045730 | 5 / 15 | 50.2× | 3.38e-8 | 4.85e-6 ✓ sig. |
| hydrogen peroxide biosynthetic process | GO:0050665 | 4 / 11 | 54.8× | 5.88e-7 | 5.37e-5 ✓ sig. |
| superoxide anion generation | GO:0042554 | 5 / 26 | 29.0× | 6.98e-7 | 6.21e-5 ✓ sig. |
| glycolytic process | GO:0006096 | 6 / 49 | 18.5× | 8.37e-7 | 7.18e-5 ✓ sig. |
| erythrocyte development | GO:0048821 | 5 / 32 | 23.5× | 2.07e-6 | 1.48e-4 ✓ sig. |
| response to nutrient | GO:0007584 | 6 / 63 | 14.4× | 3.77e-6 | 2.40e-4 ✓ sig. |
| cell surface receptor signaling pathway via JAK-STAT | GO:0007259 | 6 / 67 | 13.5× | 5.42e-6 | 3.20e-4 ✓ sig. |
| ammonium homeostasis | GO:0097272 | 3 / 6 | 75.4× | 5.62e-6 | 3.29e-4 ✓ sig. |
| response to xenobiotic stimulus | GO:0009410 | 10 / 248 | 6.1× | 6.14e-6 | 3.53e-4 ✓ sig. |
| positive regulation of interleukin-10 production | GO:0032733 | 5 / 43 | 17.5× | 9.33e-6 | 4.95e-4 ✓ sig. |
| negative regulation of apoptotic process | GO:0043066 | 14 / 524 | 4.0× | 1.01e-5 | 5.25e-4 ✓ sig. |
| superoxide metabolic process | GO:0006801 | 4 / 22 | 27.4× | 1.23e-5 | 6.14e-4 ✓ sig. |
| canonical glycolysis | GO:0061621 | 4 / 22 | 27.4× | 1.23e-5 | 6.14e-4 ✓ sig. |
| positive regulation of T-helper 2 cell cytokine production | GO:2000553 | 3 / 9 | 50.2× | 2.33e-5 | 1.01e-3 ✓ sig. |